Volume 23, Issue 1 (January 2021) 23, 85–90; 10.4103/aja.aja_20_20
Androgen downregulation of miR-760 promotes prostate cancer cell growth by regulating IL6
Shuo Wang, Yong Yang, Yu-Dong Cao, Xing-Xing Tang, Peng Du
Department of Urology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing 100142, China.
Correspondence: Dr. P Du (dupeng9000@126.com)
Date of Submission 16-Nov-2019 Date of Acceptance 13-Mar-2020 Date of Web Publication 15-May-2020
Abstract |
Prostate cancer (PCa) is one of the most common malignancies in Western countries. Studies have shown that androgen contributes to the progression of PCa, but how androgen promotes PCa remains largely unknown. Here, we demonstrated that androgen suppressed the expression of miR-760 depending on the interaction between androgen and androgen receptor (AR). miR-760 was downregulated in prostate cancer tissues compared with normal tissues. Functional experiments showed that miR-760 downregulation promoted the proliferation and growth of LNCaP and 22rv1 cells. In contrast, miR-760 ectopic expression inhibited the proliferation of LNCaP and 22rv1 cells. DNA synthesis was suppressed by miR-760. Mechanistically, miR-760 bound to the 3'UTR of interleukin 6 (IL6 ). A mutation in the binding site disrupted their interaction. In addition, silencing ofIL 6 suppressed the proliferation of LNCaP and 22rv1 cells. IL6 was upregulated in PCa tissues. Our study reveals that androgen downregulates miR-760 to promote the growth of PCa cells by regulating IL6.
Keywords: androgen; interleukin 6; miR-760; prostate cancer
Full Text |
PDF |
|
|
Browse: 868 |
|